Professional Guided Hypnosis, Self
Help, Health Issues, Personal Development, Self
Improvement: hundreds of specific areas to help you
right now ... Certified Hypnosis Downloads
In the news ...
proteins to treat muscular dystrophy. The
cell scaffolding holds muscle fibers together and protects
them from damage. Individuals who suffer from muscular
dystrophy often lack essential components in this cell
scaffold. As a result, their muscles lack strength and
become progressively weaker. The research team of
Professor Markus Rüegg at the Biozentrum, University of
Basel, has now designed two proteins that stabilize the
cell scaffolding link it to the muscle fiber and thereby
restore muscle structure and function. Science
muscular dystrophy Researchers have
demonstrated a genetic therapeutic technique that has the
potential to treat more than half of the patients
suffering from Duchenne Muscular Dystrophy (DMD).
One of the challenges of treating DMD is that the disease
can be caused by mutations to a number of different DNA
sequences, few of which occur with any substantial
frequency. The new technique gets around this sticking
point by targeting a large region of the gene that
contains many different mutations.
2 muscular dystrophy disorders Researchers
in public health have reported in the first broad study in
the United States the frequency of two muscle-weakness
disorders that strike mostly boys: Duchenne muscular
dystrophy and Becker muscular dystrophy.
About 1 in 5,000 boys, between 5 and 9 years old, have the
Parent Project Muscular Dystrophy and Foundation to Eradicate Duchenne Parent Project Muscular Dystrophy (PPMD) and Foundation to Eradicate Duchenne (FED) awards ReveraGen BioPharma (ReveraGen) a $1 million grant. The grant will help fund ReveraGen's VBP15, a combined action drug that addresses multiple levels of the muscle disease Duchenne muscular dystrophy (Duchenne). Parent Project Muscular Dystrophy
Genetic source of muscle weakness Scientists at the Translational Genomics Research Institute (TGen), using state-of-the-art genetic technology, have discovered the likely cause of a child's rare type of severe muscle weakness. The child was one of six cases in which TGen sequenced -- or decoded -- the genes of patients with Neuromuscular Disease (NMD) and was then able to identify the genetic source, or likely genetic source, of each child's symptoms.
"In all six
cases of myopathy, or muscle weakness, these children had
undergone extensive, expensive and invasive testing --
often over many years -- without a successful diagnosis,
until they enrolled in our study," said Dr. Lisa
Baumbach-Reardon, an Associate Professor of TGen's
Integrated Cancer Genomics Division. "Our results
demonstrate the diagnostic value of a comprehensive
approach to genetic sequencing," said Dr.
Baumbach-Reardon. "This type of next-generation sequencing
can greatly improve the ability to identify pathogenic, or
disease-causing, genetic variants with a single, timely,
Also of interest
REIKI FAQS - Questions and Answers, Reiki Clinic, Reiki Training, Reiki Courses
© All rights reserved
Concise Encyclopedia.com, Research Online, Search Engines, Dictionaries, Reference Desk, Wikipedia encyclopedia, World encyclopedia, Internet encyclopedia, and unlimited Internet Resources ...